Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
LIVEWest Ham vs Man City - Premier League LIVE: Title race over? Reaction as Pep Guardiola's side FAIL to win and trail Arsenal by NINE points after dramatic day Follow Daily Mail Sport's live blog ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results